CORE NATURAL RESOURCES INC (CNR) Fundamental Analysis & Valuation

NYSE:CNR • US2189371006

Current stock price

89.37 USD
+1.39 (+1.58%)
At close:
89.37 USD
0 (0%)
After Hours:

This CNR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

2

1. CNR Profitability Analysis

1.1 Basic Checks

  • In the past year CNR has reported negative net income.
  • CNR had a positive operating cash flow in the past year.
  • CNR had positive earnings in 4 of the past 5 years.
  • In the past 5 years CNR always reported a positive cash flow from operatings.
CNR Yearly Net Income VS EBIT VS OCF VS FCFCNR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M 800M

1.2 Ratios

  • CNR has a worse Return On Assets (-2.50%) than 74.16% of its industry peers.
  • Looking at the Return On Equity, with a value of -4.17%, CNR is doing worse than 70.33% of the companies in the same industry.
Industry RankSector Rank
ROA -2.5%
ROE -4.17%
ROIC N/A
ROA(3y)10.66%
ROA(5y)10.11%
ROE(3y)20.97%
ROE(5y)21.61%
ROIC(3y)N/A
ROIC(5y)N/A
CNR Yearly ROA, ROE, ROICCNR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 20 30 40

1.3 Margins

  • Looking at the Gross Margin, with a value of 14.89%, CNR is doing worse than 68.42% of the companies in the same industry.
  • In the last couple of years the Gross Margin of CNR has declined.
  • CNR does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 14.89%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-45.52%
GM growth 5Y-31.12%
CNR Yearly Profit, Operating, Gross MarginsCNR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60 80

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

4

2. CNR Health Analysis

2.1 Basic Checks

  • CNR does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for CNR has been increased compared to 1 year ago.
  • Compared to 5 years ago, CNR has more shares outstanding
  • CNR has a worse debt/assets ratio than last year.
CNR Yearly Shares OutstandingCNR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M 50M
CNR Yearly Total Debt VS Total AssetsCNR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.2 Solvency

  • CNR has an Altman-Z score of 1.99. This is not the best score and indicates that CNR is in the grey zone with still only limited risk for bankruptcy at the moment.
  • CNR has a better Altman-Z score (1.99) than 61.24% of its industry peers.
  • CNR has a debt to FCF ratio of 21.37. This is a negative value and a sign of low solvency as CNR would need 21.37 years to pay back of all of its debts.
  • Looking at the Debt to FCF ratio, with a value of 21.37, CNR is in line with its industry, outperforming 45.93% of the companies in the same industry.
  • A Debt/Equity ratio of 0.10 indicates that CNR is not too dependend on debt financing.
  • CNR's Debt to Equity ratio of 0.10 is fine compared to the rest of the industry. CNR outperforms 78.95% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 21.37
Altman-Z 1.99
ROIC/WACCN/A
WACC9.04%
CNR Yearly LT Debt VS Equity VS FCFCNR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

2.3 Liquidity

  • CNR has a Current Ratio of 1.60. This is a normal value and indicates that CNR is financially healthy and should not expect problems in meeting its short term obligations.
  • CNR's Current ratio of 1.60 is fine compared to the rest of the industry. CNR outperforms 67.94% of its industry peers.
  • CNR has a Quick Ratio of 1.15. This is a normal value and indicates that CNR is financially healthy and should not expect problems in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 1.15, CNR is in line with its industry, outperforming 59.33% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.6
Quick Ratio 1.15
CNR Yearly Current Assets VS Current LiabilitesCNR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 200M 400M 600M 800M 1B

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. CNR Growth Analysis

3.1 Past

  • The earnings per share for CNR have decreased strongly by -118.73% in the last year.
  • The Revenue has grown by 88.44% in the past year. This is a very strong growth!
  • The Revenue has been growing by 32.89% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-118.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-248.08%
Revenue 1Y (TTM)88.44%
Revenue growth 3Y21.92%
Revenue growth 5Y32.89%
Sales Q2Q%75.12%

3.2 Future

  • The Earnings Per Share is expected to grow by 91.74% on average over the next years. This is a very strong growth
  • CNR is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.88% yearly.
EPS Next Y293.4%
EPS Next 2Y157.19%
EPS Next 3Y91.74%
EPS Next 5YN/A
Revenue Next Year6.81%
Revenue Next 2Y6.82%
Revenue Next 3Y4.88%
Revenue Next 5YN/A

3.3 Evolution

  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
CNR Yearly Revenue VS EstimatesCNR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B 4B
CNR Yearly EPS VS EstimatesCNR Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 5 10 15

More info and screens

Find the best growth stocksShow best growing peers

3

4. CNR Valuation Analysis

4.1 Price/Earnings Ratio

  • CNR reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
  • With a Price/Forward Earnings ratio of 25.67, CNR can be considered very expensive at the moment.
  • CNR's Price/Forward Earnings is on the same level as the industry average.
  • CNR is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 21.99, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE N/A
Fwd PE 25.67
CNR Price Earnings VS Forward Price EarningsCNR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CNR is on the same level as its industry peers.
  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of CNR is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 214.23
EV/EBITDA 9.19
CNR Per share dataCNR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • CNR's earnings are expected to grow with 91.74% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y157.19%
EPS Next 3Y91.74%

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

1

5. CNR Dividend Analysis

5.1 Amount

  • With a yearly dividend of 0.46%, CNR is not a good candidate for dividend investing.
  • CNR's Dividend Yield is slightly below the industry average, which is at 3.22.
  • With a Dividend Yield of 0.46, CNR pays less dividend than the S&P500 average, which is at 1.82.
Industry RankSector Rank
Dividend Yield 0.46%

5.2 History

  • The dividend of CNR decreases each year by -0.11%.
  • CNR has been paying a dividend for over 5 years, so it has already some track record.
Dividend Growth(5Y)-0.11%
Div Incr Years0
Div Non Decr Years0
CNR Yearly Dividends per shareCNR Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 2026 0.5 1 1.5 2 2.5

5.3 Sustainability

  • CNR has negative earnings and hence a negative payout ratio. The dividend may be in danger.
DP-17.14%
EPS Next 2Y157.19%
EPS Next 3Y91.74%
CNR Yearly Income VS Free CF VS DividendCNR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 200M 400M 600M

More info and screens

Find the best dividend stocksShow peers with best dividend

CNR Fundamentals: All Metrics, Ratios and Statistics

CORE NATURAL RESOURCES INC

NYSE:CNR (4/28/2026, 8:22:07 PM)

After market: 89.37 0 (0%)

89.37

+1.39 (+1.58%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)02-12
Earnings (Next)05-07
Inst Owners96.87%
Inst Owner Change0.22%
Ins Owners2.47%
Ins Owner Change-0.62%
Market Cap4.54B
Revenue(TTM)4.16B
Net Income(TTM)-153.22M
Analysts82.22
Price Target115.03 (28.71%)
Short Float %3.32%
Short Ratio1.6
Dividend
Industry RankSector Rank
Dividend Yield 0.46%
Yearly Dividend0.65
Dividend Growth(5Y)-0.11%
DP-17.14%
Div Incr Years0
Div Non Decr Years0
Ex-Date03-02
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-75.11%
Min EPS beat(2)-334.4%
Max EPS beat(2)184.18%
EPS beat(4)1
Avg EPS beat(4)-117.04%
Min EPS beat(4)-334.4%
Max EPS beat(4)184.18%
EPS beat(8)4
Avg EPS beat(8)-50.14%
EPS beat(12)7
Avg EPS beat(12)-33.43%
EPS beat(16)10
Avg EPS beat(16)-22.16%
Revenue beat(2)1
Avg Revenue beat(2)-0.82%
Min Revenue beat(2)-3.04%
Max Revenue beat(2)1.41%
Revenue beat(4)3
Avg Revenue beat(4)3.26%
Min Revenue beat(4)-3.04%
Max Revenue beat(4)11.91%
Revenue beat(8)6
Avg Revenue beat(8)1.6%
Revenue beat(12)9
Avg Revenue beat(12)3.09%
Revenue beat(16)13
Avg Revenue beat(16)8.98%
PT rev (1m)1.42%
PT rev (3m)-0.9%
EPS NQ rev (1m)-30.97%
EPS NQ rev (3m)-77.08%
EPS NY rev (1m)-12.67%
EPS NY rev (3m)-56.59%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.99%
Revenue NY rev (1m)0.2%
Revenue NY rev (3m)-2.15%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 25.67
P/S 1.09
P/FCF 214.23
P/OCF 14.83
P/B 1.23
P/tB 1.23
EV/EBITDA 9.19
EPS(TTM)-1.8
EYN/A
EPS(NY)3.48
Fwd EY3.9%
FCF(TTM)0.42
FCFY0.47%
OCF(TTM)6.02
OCFY6.74%
SpS82.06
BVpS72.48
TBVpS72.48
PEG (NY)N/A
PEG (5Y)N/A
Graham Number0 (-100%)
Profitability
Industry RankSector Rank
ROA -2.5%
ROE -4.17%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 14.89%
FCFM 0.51%
ROA(3y)10.66%
ROA(5y)10.11%
ROE(3y)20.97%
ROE(5y)21.61%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-45.52%
GM growth 5Y-31.12%
F-Score4
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 21.37
Debt/EBITDA 0.73
Cap/Depr 45.82%
Cap/Sales 6.83%
Interest Coverage N/A
Cash Conversion 62.63%
Profit Quality N/A
Current Ratio 1.6
Quick Ratio 1.15
Altman-Z 1.99
F-Score4
WACC9.04%
ROIC/WACCN/A
Cap/Depr(3y)64.99%
Cap/Depr(5y)65.94%
Cap/Sales(3y)7.22%
Cap/Sales(5y)7.87%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-118.73%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-248.08%
EPS Next Y293.4%
EPS Next 2Y157.19%
EPS Next 3Y91.74%
EPS Next 5YN/A
Revenue 1Y (TTM)88.44%
Revenue growth 3Y21.92%
Revenue growth 5Y32.89%
Sales Q2Q%75.12%
Revenue Next Year6.81%
Revenue Next 2Y6.82%
Revenue Next 3Y4.88%
Revenue Next 5YN/A
EBIT growth 1Y-140.68%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1049.37%
EBIT Next 3Y139.8%
EBIT Next 5YN/A
FCF growth 1Y-92.91%
FCF growth 3Y-64.66%
FCF growth 5Y-13.33%
OCF growth 1Y-35.82%
OCF growth 3Y-22.27%
OCF growth 5Y18.78%

CORE NATURAL RESOURCES INC / CNR Fundamental Analysis FAQ

What is the fundamental rating for CNR stock?

ChartMill assigns a fundamental rating of 3 / 10 to CNR.


What is the valuation status of CORE NATURAL RESOURCES INC (CNR) stock?

ChartMill assigns a valuation rating of 3 / 10 to CORE NATURAL RESOURCES INC (CNR). This can be considered as Overvalued.


Can you provide the profitability details for CORE NATURAL RESOURCES INC?

CORE NATURAL RESOURCES INC (CNR) has a profitability rating of 2 / 10.


What is the earnings growth outlook for CORE NATURAL RESOURCES INC?

The Earnings per Share (EPS) of CORE NATURAL RESOURCES INC (CNR) is expected to grow by 293.4% in the next year.